Bahrain Pharmaceuticals & Healthcare Q3 2006

Published by: Business Monitor International

Published: Sep. 1, 2006 - 56 Pages

Table of Contents

Chapter 1 - Executive Summary

Bahrain Pharmaceuticals & Healthcare Industry SWOT

Chapter 2 - Bahrain: Business Environment Ranking

Table: Business Environment Ranking: Middle East & Africa

Business Environment Ranking

Economics - Long-Term Risk

Politics - Long-Term Risk

Regulatory Barriers

Domestic Sector Threat

Market Growth Potential

Market Size Ranking

Chapter 3 - Market Summary

Chapter 4 - Regulatory Regime

Intellectual Property Developments

Pricing & Reimbursement Issues

Mandatory Health Insurance

Chapter 5 - Industry Developments

Healthcare Sector

Primary Healthcare

Secondary and Tertiary Healthcare

Environment & Occupational Healthcare

Strategic Healthcare Goals

Lifestyle Change and Diabetes

HIV/AIDS

International Collaboration

Investment & Expansion

Pharmaceutical Sector

US FTA Impact on Pharmaceutical Sector

Chapter 6 - Industry Forecast Scenario

Key Growth Factors - Industry

Table - Bahrain Pharmaceuticals Sector - Historical Data & Forecasts

Key Growth Factors - Macroeconomic

Table: Bahrain - Economic Activity

Table: Bahrain: Macroeconomic Data And Forecasts

Prescription Market Forecast

Table - Prescription Drug Market Forecast

OTC Market Forecast

Table - Prescription Drug Market Forecast

Generics Market Forecast

Table - Prescription Drug Market Forecast

Export/Import Market Forecast

Table - Prescription Drug Market Forecast

Other Healthcare Data Forecasts

Bahrain Pharmaceuticals & Healthcare Report Q3 2006

Table - Prescription Drug Market Forecast

Key Risks to BMI’s Forecast Scenario

Chapter 7 - Company Profiles

Novartis

Johnson & Johnson

Sanofi-Aventis

Bahrain Industrial Pharmaceutical Co. (Bidapharm)

Chapter 8 - BMI Forecast Modelling

How we generate our industry forecasts

Pharmaceutical Industry

Chapter 9 - Appendix: Regional Demographic Data

The Long View: Data Over The Economic Cycle (2000-2007)

Population

Household Spending Per Capita, US$

Private Consumption Per Capita, US$ PPP

Market Size, GDP, US$bn

Chapter 10 - Country Snapshot: Bahrain Demographic Data

Section 1: Population:

Table: Demographic Indicators (2005)

Table: Rural/Urban Breakdown

Section 2: Education & Healthcare

Table: Education

Table: Healthcare: Vital Statistics

Table: Healthcare: Expenditure

Section 3: Labour Market And Spending Power

Table: Employment Indicators

Table: Consumption and Stratification

Table: Wages per year

Abstract

Bahrain's drug market is relatively small by regional standards, worth only US$49.2mn in 2005, although, as forecast in BMI's recently released Bahrain Pharmaceuticals & Healthcare report, growth is expected to be strong in the coming years, with the market size expected to almost double by 2010.

Solid economic growth and a rapidly expanding population are two macro factors that are helping to pull the market upwards. The healthcare system is undergoing rapid modernisation, with the government focusing on improving primary care, and recently announcing a scheme that will see all expatriate workers covered by private health insurance by 2013. This will reduce public health expenditure and is part of a government strategy to offload more of the burden of health spending to the private sector.

Bahrain's recent Free Trade Agreement (FTA) with the US should also have a beneficial impact. As well as making US-produced drugs more available, the FTA has significantly tightened Bahrain's intellectual property laws. This in turn will encourage foreign investment in the market. The domestic manufacturing sector is small, comprising just four companies producing basic drugs. However, Bahrain Industrial Pharmaceutical (Bidapharm), currently a pharmaceuticals importer, is in the process of building a manufacturing plant, which will make it the country's fifth producer.

BMI's adjusted Business Environment Rankings for the Middle East reveal that Bahrain is in 2nd place behind only the UAE. This is primarily due to forecasts of high market growth, coupled with the country's world class intellectual property (IP) regime. Bahrain's limited domestic manufacturing industry and lack of technological capabilities has also made the country an excellent investment opportunity for foreign drugmakers, although the outlook is tempered somewhat by the small overall market size.

Key Benefits of Report

Rely On Our Independent 5-Year Forecasts As A Benchmark
to test other views - a key input for successful budgetary and strategic business planning.

Target Business Opportunities & Risks
through our reviews of latest industry trends, regulatory changes, and major deals, projects and investments

Exploit Latest Competitive Intelligence & Company SWOTS
on your competitors and peers through company rankings by sales, market share and ownership structure - includes multinational and national companies.

Get Full Details About This Report >>

About MarketResearch.com
MarketResearch.com is an online aggregator selling over 300,000 market research reports, company profiles and country profiles from over 700 research firms. Our reports will provide you with the critical business and competitive intelligence you need for strategic planning and marketing research. Coverage includes the US, UK, Europe, Asia and global markets.